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Å: Armstrongs 
AB: alamarBlue®  
CAS no: Chemical abstracts service number 
CEC: Cation exchange capacity  
CFDA-AM: 5-carboxyfluorescein diacetate, acetoxymethyl ester (CFDA-AM) probe  
DLS: Dynamic Light Scattering 
FTIR: Fourier Transform InfraRed 
HDTA: Hexadecyl Trimethyl ammonium bromide 
LOEC: Lowes observed effect concentration 
NRU: Neutral red uptake 
OECD: Organisation for Economic Co-operation and Development 
QAC: Quaternary ammonium compound 
REACH: Registration, Evaluation, Authorisation and Restriction of Chemicals 
TGA: Thermogravimetric analysis  
TMSA: Octadecyl trimethyl Ammonium chloride 
TNF-α: Tumor Necrosis Factor-α 
TEM: Transmission electron microscopy 
XRD: X-ray diffraction 
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Abstract 
Organically modified clays can be used as nanofillers in polymer-clay nanocomposites to create bio-
based packaging with improved strength and barrier properties. The impact of organic modification 
on the physico-chemical properties and toxicity of clays has yet to be fully investigated but is 
essential to ensure their safe use. Two organoclays, named N116_HDTA and N116_TMSA, were 
prepared using a commercially available sodium bentonite clay and organic modifiers hexadecyl 
trimethyl ammonium bromide (HDTA) and octadecyl trimethyl ammonium chloride (TMSA). An in 
vitro hazard assessment was performed using HaCaT skin cells, C3A liver cells and J774.1 
macrophage-like cells. Organic modification with HDTA and TMSA increased the hazard potential of 
the organoclays in all cell models, as evidenced by the higher levels of cytotoxicity measured. 
N116_TMSA caused the greatest loss in viability with IC50 values of 3.2, 3.6 and 6.1 µg/cm2 
calculated using J774.1, HaCaT and C3A cell lines, respectively. Cytotoxic effects were dictated by the 
amount of free or displaced organic modifier present in the exposure suspensions. However, the 
parent bentonite clay also caused distinct cytotoxic effects in J774.1 macrophage-like cells with 
associated TNF-α release. Such information on the hazard profile of organoclays, can feed into risk 
assessments for these materials.  
Keywords; bentonite clays; organic modification; nanofillers; hazard assessment; cytotoxicity; in 
vitro 
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1. Introduction 
Clays are found ubiquitously in the environment, particularly in soils and sediments. Natural forms of 
clays have been used in the past as topical antibacterial agents and even as oral treatments for 
gastrointestinal disorders (Williams and Haydel 2010). More recently, advances in modern-day 
material engineering has led to the use of both natural and synthetic clays in a wide variety of 
industries and sectors (Patel et al. 2006). The ease of chemical modification of the clays, by using 
exchangeable cations and organic species, is leading to a new cohort of modified clays becoming 
commercially available. Modifications can be used to alter the physico-chemical properties of clays 
such as particle size, surface area, surface charge, porosity, as well as absorptive and cation 
exchange capacity for wider applications. Applications of modified clays now range from additives in 
commercial products to enhance rheological properties (e.g. inks, paints and cosmetics) to their use 
in enzyme immobilisation platforms and waste-water treatment technologies which capitalise on 
their high absorptive capacity (Kurzbaum et al. 2017).  As a result, clays now fall into the category of 
high volume production materials that are used in thousands of tons in modern industry (25,000-
51,000 tons globally) with future production volumes expected to increase (Future Markets 2015). 
At present, the greatest single use for clays is as reinforcing nanofillers in the polymer 
nanocomposite industry (22 % of targeted market) (Future Markets 2011). Clays incorporated into 
different polymeric matrices can be used to confer strength, enhance barrier properties and flame-
retardant properties to the finished polymer-clay nanocomposite materials (Nguyen and Baird 2006, 
Powell and Beall 2006). The clays used are typically modified to improve compatibility with polymer 
matrices by replacing the native interlayer cations (e.g. Na+, Ca2+) of the clays with organic ions (e.g. 
Al3+, PH4+, NH4+). A range of different alkylammonium bromides or chlorides, sulfonium, or 
phosphonium surfactants can be used in the organic modification process, and typically organoclays 
contain between 4-40% by weight of organic modifier (Southern Clay Products, USA). There is a very 
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large market for organoclay-reinforced materials in automotive and aerospace parts as well as in 
food packaging applications (Jorda Beneyto et al. 2014). The organoclays assessed in this study are 
being specifically investigated for their potential use in the production of biodegradable poly-lactic 
acid (PLA)-clay based nanocomposite packaging materials for the cosmetic industry. 
Clays have a large variability in composition, exchangeable ions, accessory mineral constituents and 
transition metals (e.g. Fe, Mg, Ca) are present in small and varying amounts according to origin and 
purity. They can be defined loosely as hydrous silicates, classified based on geometry (e.g. sheet like, 
tubular or fibrous) and structure (layers), and distinguished based on the arrangement of structural 
units (octahedral and tetrahedral sheets) (Uddin 2008). The sodium bentonite clays investigated in 
this study are hydrous aluminosilicate layered clays formed from the devitrification of volcanic ash. 
They have sodium as the predominant exchange cation and they are most commonly used in 
polymer nanocomposites due to their excellent plasticity, good mechanical and chemical resistance 
and high ion exchange capacity. The main component of the sodium bentonite clay is the mineral 
montmorillonite. Its basic structural unit is composed of several high-aspect ratio sheets (~1nm thick 
and between 200-300 nm long) (two silica sheets and one alumina sheet) arranged in layers (2:1 
type) held together by weak Van der Waals and electrostatic forces (figure 1). These platelet- type 
aluminium silicate clays have a very large specific surface area (600-800 m2/g) and high aspect ratio 
(100-150:1); characteristics that can confer toxicity (Fubini et al. 2011; Verma et al. 2012). 
Furthermore, bentonite clays can contain a fraction of quartz, a substance known to be carcinogenic 
and cause fibrosis upon inhalation (Perry 1959; Donaldson and Borm 1998). 
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Figure 1 Diagrammatic representation of the structure of the sodium bentonite parent clay (N116) 
used in this study and the interlayer organic modification process through exchange of ions.      
As well as their small size, large surface area and high aspect ratio, clays have high dustiness; a 
property that increases the likelihood for exposure, particularly via inhalation. The production and 
processing of large quantities of dust-like clays with a respirable fraction (<4 µm) during 
nanocomposite manufacturing will result in potential lung exposure. In addition, skin contact in an 
occupational (e.g. at the polymer production site) setting is likely. Information on occupational 
exposure to clays during extraction, processing and application to polymer composites is limited. 
However, the presence of airborne clays through handling tasks performed during compounding of 
clays to formulate nanocomposites has been identified (Tsai et al. 2012). Concentrations of clay 
particles <560 nm measured, ranged from 12,390 particles/cm3- 130,980 particles/cm3.  The upper 
values are well above the proposed nano reference value or exposure limit value for clays (40,000 
particles/cm3) set as a precautionary approach to control workplace concentrations of 
nanomaterials (van Broekhuizen and Dorbeck-Jung 2013).  When used in a nanocomposite 
packaging, the clays will be embedded in the polymer matrix. Therefore, from a consumer 
perspective, the clays will only pose a potential risk following migration from the packaging (e.g. into 
the cosmetic). Accordingly, migration of the clays from the packaging may lead to exposure of the; 
skin, gastrointestinal tract (via hand to mouth contact) or secondary target sites (e.g. the liver, 
following translocation into the circulation) ((Wu et al. 2009; Schleh et al. 2012). The potential for 
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nanomaterials to migrate from packaging materials into food has been reported previously 
(Echegoyen et al. 2016). However, exposure concentrations for consumers are likely to be orders of 
magnitude lower than would be experienced by workers handling clays in a manufacturing setting.  
Despite this, investigations into the toxic potential of clays are limited. Although they have been 
recognised by the OECD as a group of manufactured nanomaterials with high priority for testing, 
studies on their impact on human health are currently limited (OECD 2015). Early reports of 
cytotoxic effects of aluminium silicate clays (bentonite and montmorillonite) towards certain cell 
types (e.g. human umbilical vein endothelial cells and primary murine spinal cord neurons) were 
made by Murphy et al. (1993a, b).  Subsequent studies also have evidenced cytotoxic effects 
associated with exposure of lung cells (A549 cells; Verma et al. 2012), and liver cells (HepG2 cells; 
Loordan et al. 2011; Baek and Lee 2012) in vitro as well as recent evidence of acute liver injury in 
vivo in mice following administration via the tail vein (Isoda et al. 2017). In fact, in a comparative 
study clays were ranked as the most cytotoxic compared to other commonly used nanofillers (e.g. 
silica, silver, ZnO and calcium carbonate) (NanoSafepack 2012; Nones et al. 2015). However, the lack 
of concurrent data on clay toxicity makes it challenging to reach a definitive conclusion regarding 
their hazard potential. This leads to uncertainties surrounding the risk they pose to human health 
(Maisanaba et al. 2015). Accordingly, it is prudent to compare the toxicity of clays to different cell 
types in vitro in one study. 
Clays are commonly modified to improve their functionality in products. However, very little 
consideration has been given to what effects modification may have on the physico-chemical 
properties and/or toxicity of organoclays in the context of a safety assessment. The organic 
modifiers hexadecyl trimethyl ammonium bromide (HDTA) and octadecyl trimethyl ammonium 
chloride (TMSA), were used in this study to make the clays more compatible with the polymer matrix 
of a novel cosmetic packaging being developed. Both modifiers belong to a group of quaternary 
ammonium compounds (QACs) commonly used in cation exchange reactions to modify clays for 
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polymer-clay nanocomposites. While permitted for use as additives in personal care products 
(European Commission 2009), certain QACs have been shown to stimulate cytotoxic effects in vitro 
(Madine-Darby canine kidney (MDCK) II cells; Inacio et al. 2013), impair reproductive health in mice 
(Melin et al. 2014) and cause skin and respiratory irritation in vivo at higher concentrations (Lin and 
Hemming 1996; Larsen et al. 2012). Adverse effects are thought to be related to the alkyl chain 
length, cationic nature and structure of the specific QAC (Rhein et al. 1986, Lin and Hemming 1996). 
Toxicological data for the QACs used in this study (HDTA and TMSA) are lacking. However, the 
potential role of organic modifiers in the toxicity of organoclays has been eluded to in previous 
studies (Janer et al. 2014; Sharma et al. 2010; Sharma et al. 2014). Presently, organically-modified 
clays have been designated with individual chemical abstracts service (CAS) numbers. However, they 
are exempt from registration under REACH, as despite their surface modification the structure of the 
clay mineral does not change and therefore it is not considered a new chemical entity. Instead 
registration of the organic modifier itself will suffice (Article 3(39), Article 3(40) and Annex V (7) of 
REACH (European Commission 2006)). However, it is essential to investigate if exposure to both the 
clay and organic modifier will result in an increased hazard. Such information will feed into the 
regulation of organoclays to ensure their safe use and can be used to inform the safe design of 
future generations of organoclays. 
The main aim of this study was to provide information on the potential cytotoxic and inflammatory l 
hazards (from occupational and consumer perspectives) of organoclays for their safe use as 
nanofillers in polymer-clay nanocomposite packaging materials. Any potential adverse effects 
associated with exposure to workers and end users was assessed using relevant and representative 
in vitro cellular models for target organs (skin, liver, lungs), namely HaCaT human keratinocytes, C3A 
liver cells and J774.1 macrophage-like cells. These cells were selected as keratinocytes are the main 
cell type of the human dermis and epidermis forming the skin barrier, macrophages play a key role in 
the clearance of inhaled nanomaterials (Geiser et al. 2008), and nanomaterials have been 
demonstrated to accumulate primarily in the liver following exposure via several routes (e.g. Choi et 
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al. 2010; Wang et al. 2007). The use of in vitro systems improves the alignment of nanotoxicology 
studies with the 3Rs principles (Replacement, Reduction and Refinement), in order to reduce the 
reliance placed on animal testing (Burden et al. 2017; Johnston et al. 2018) and allows a quick and 
cheap screen of organoclay toxicity to be performed. A robust (3-in-1) cytotoxicity screening assay 
system (Connolly et al. 2015) was applied to compare the toxicity of the parent and modified clays in 
order to rank their potency and to compare the sensitivity of the different cell types being 
investigated. Both unmodified (N116) and organically modified clays (N116_HDTA and N116_TMSA) 
were included, as well as an assessment of the cytotoxic potential of the organic modifiers alone to 
elucidate the contribution of organic modifier to any adverse effects observed. The ability of the 
clays to elicit inflammatory responses (TNF-α) in J774.1 macrophage-like cells was assessed and 
studies on clay and J774.1 cellular interaction were performed using microscopy.   
2. Materials and methods 
2.1. Clay modification 
A commercially available natural sodium bentonite clay (Nanofil®116 (N116) (CAS no: 1302-78-9)) 
was purchased from BYK Additives & Instruments, Wesel, Germany. The manufacturers reported 
clay particle size was between 1-5 µm and it had a high cation exchange capacity (CEC): 116 
mEq/100g (BYK Additives & Instruments, 2016). The organic modifiers hexadecyl trimethyl 
ammonium bromide (HDTA) (CAS no. 57-09-0) and octadecyl trimethyl ammonium chloride (TMSA) 
(CAS no. 112-03-8) were supplied by CymitQuimica S.L., Barcelona, Spain. The clay was organically 
modified using a cationic exchange reaction, whereby sodium cations present in the clay were 
exchanged for ammonium cations of the respective organic modifiers.. The final amount intercalated 
according to thermogravimetric analysis (TGA) results were: HDTA (27.3 g/100 g clay) and TMSA 
(29.5 g/100 g clay). The organically modified clays (organoclays) were termed N116_HDTA and 
N116_TMSA respectively throughout this study, according to the modifier used. 
2.2. Organoclay characterisation 
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The organoclays were characterised using thermogravimetric analysis (TGA), Fourier transform 
infrared (FTIR) spectrophotometry and X-ray diffraction (XRD). FTIR spectrophotometry was used to 
determine the surface structure of the clay minerals and modifiers and to qualitatively determine 
the presence of the organic modifiers in the organoclays. A Tensor 27 model Infrared 
spectrophotometer with an attenuated total reflectance (ATR) module, with monolithic diamond 
crystal for full spectral range from 4000 - 500 cm-1, was used (Bruker, Bremen, Germany). 
A wide-angle X-ray powder Diffractometer (D8 Advance A25 (Bruker, Bremen, Germany)) was used 
to measure the distance between the individual layers of the clay when the organic modifiers are 
intercalated between them. The interlayer spacing (D001) was calculated from the XRD spectrum 
according to the 2ϴ angles corresponding to the diffraction peaks of the organoclay by the Bragg’s 
Law, whose formula is:  
nλ= 2d sinθ  
Where, n is the order of diffraction, λ is the wave length, θ is the angle of diffraction and d- inter 
planar distance. According to Bragg’s law, the d-spacing is inversely proportional to the scattering 
angle. Therefore, any shifts of the peaks to lower scattering angles corresponds to larger d-spacing 
and hence larger distances between the silicate layers will be found. 
Thermogravimetric analysis (TGA) was performed on clay powders using a TA Q5000IR 
thermobalance (TA instruments, Newcastle, USA) to quantify the total amount of modifier in each 
organoclay. A total of 10.0 mg of sample (clay powders) was heated from 25 to 900°C at a heating 
rate of 20°C per min in a nitrogen atmosphere. 
2.3. Preparation and Characterisation of clay suspensions  
Suspensions of organoclays (N116_HDTA, N116_TMSA) and the parent sodium bentonite clay (N116) 
were prepared according to the ENPRA protocol which was developed for preparation of dispersions 
of engineered nanomaterials for toxicity testing (Jacobsen, 2010). According to this protocol 
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nanomaterials are coated with serum prior to dispersion in culture medium. This has been shown to 
reduce clay/medium interactions (e.g. ion exchange reactions) in in vitro cell culture testing 
platforms (Katic et al. 2006) and thus was considered an appropriate methodology. Aqueous 
dispersions of clays (1 mg/mL) were first prepared in 2% (v/v) bovine serum albumin (BSA) (in water) 
and then sonicated (water bath sonication, 400 W power (VWR, Leicestershire, UK) for 16 min. Clay 
dispersions were then diluted immediately, in cell culture medium (37°C) according to the 
requirements of the different cell types. Test suspension concentrations ranged from 0.3-100 µg/mL 
(equivalent to 0.24-31.25 µg/cm2). 
Dynamic light scattering (DLS) was used to characterise the hydrodynamic size distribution of the 
clays in cell culture medium, at the highest test suspension concentration (100 µg/ml) and to 
monitor if the dispersion was stable over the exposure period (T0-T24 h) when incubated at 37°C/5% 
CO2. A Zetasizer Nano-ZS (Malvern Panalytical, Malvern, UK) was used to take measurements 
directly after preparation and after 24 h. Test suspensions were agitated/resuspended prior to 
taking measurements. Z-average values and polydispersity indices (PDI) (mean ± standard deviation) 
have been used as a measure of the average size and width of the particle size distribution in test 
suspensions (Zetasizer Software version 6.34 (Malvern Panalytical, Malvern, UK)).   
Suspensions of each clay (in cell culture medium; 100 ug/mL) were also visualised using an inverted 
light microscope (Axiovert 40C (Carl Zeiss, Cambridge, UK)) equipped with a Canon EOS 1000D 
(Canon, Surrey, UK). The clay suspensions were also deposited onto copper grids and viewed in a 
JEOL JEM-1400 Plus transmission electron microscope (JOEL Inc., Peabody, MA USA) operating at an 
accelerating voltage of 200 kV. Micrographs were taken using a GATAN OneView camera (GATAN, 
Pleasanton, CA, USA). 
2.4. Cell culture and maintenance 
The murine macrophage-like cell line, J774.1, the human keratinocyte skin cell line, HaCaT, and the 
human hepatocellular liver carcinoma cell line, C3A, were all used. J774.1 cells (ECACC, Porton 
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Down, UK) were cultured in RPMI 1640 medium (Thermo Fischer Scientific, Cramlington, UK) 
supplemented with 1 mM sodium pyruvate and 1% non-essential amino acids. C3A cells (ATCC; 
Manassas, VA, USA) were cultured in minimum essential medium supplemented with L-Alanyl-
Glutamine (MEM, GlutaMAX™ (Sigma Aldrich, Dorset UK)). HaCaT cells (CLS cell lines service, 
Eppelheim, Germany) were cultured in dulbecco's modified eagle's medium (DMEM) with a high 
glucose content (4.5 g/L) (Thermo Fisher Scientific, Cramlington, UK) supplemented with 2mM L-
glutamine.  
All media were supplemented with 10% heat-inactivated foetal bovine serum (FBS) (Thermo Fisher 
Scientific, Cramlington, UK, 100 U/ml Penicillin and 100 μg/ml Streptomycin (Gibco, USA) and cells 
were maintained in 75 cm2 culture flasks (Corning, USA) at 37°C with 5% CO2, 95% air in a humidified 
incubator.  
2.5. Clay exposures 
Cells were seeded into 96 well plates at a density of 5 x 105 cells/mL, 4 x 105 cells/ml and 2.5 x105 
cells/mL (100ul/well) for J774.1, C3A, and the HaCaT cells, respectively and incubated at 37°C/ 5% 
CO2for 24 h. Cells were then exposed (in triplicate) to the clays (N116 clay and modified N116_HDTA 
and N116_TMSA organoclays) at a concentration range of 0.3-100 ug/ml (100 μl/well) (equivalent to 
0.24 to 31.25 µg/cm2) for 24 h. Cells were also exposed to the organic modifier HDTA and TMSA 
(0.049-12.5 µg/mL (100ul/well))(0.015-3.9 µg/cm2). The modifiers were first solubilised in ethanol 
(20 mg/mL) and subsequently diluted in cell culture medium. Cells exposed to cell culture medium 
only served as negative controls. 5 % ethanol was used as a positive control. Assays showing cellular 
viability of between 15-20 % following 24 h exposure to the positive control were considered valid. 
Vehicle controls (0.2% v/v ethanol and 0.2% (v/v) aqueous BSA solution were also included.  
The concentration range was selected by taking into consideration the potential levels of exposure 
from use of a cosmetic cream (30 mL) that has been packaged using a polymer-nanocomposite 
packaging (4 % w/w clay). The concentration range incorporates a worst-case and a theoretical low 
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exposure scenario in which all (100%) or a small fraction (10%) of organoclays present in a polymer-
nanocomposite packaging is released into a cosmetic formulation and a subsequent single 
application (2mg/cm2) to the skin. The theoretical worst case and low exposure scenario levels to 
organoclays are 8 and 0.8 µg/cm2, respectively (Additional file 1, figure 1). An exposure scenario has 
also been performed for the organic modifiers only with worst case scenario concentrations of 2.2 or 
2 µg/cm2 and lowerconcentrations 0.19 and 0.17 µg/cm2 for HDTA and TMSA, respectively 
(Additional file 1, figure 2).   
2.6. Cytotoxicity Assessment  
A 3 in 1 fluorometric-based assay system was used to assess cytotoxicity following exposure of the 
skin, liver and immune cells to test suspensions. This system facilitates the application of three 
different assay reagents (namely alamarBlue® (AB), a 5-carboxyfluorescein diacetate, acetoxymethyl 
ester (CFDA-AM) probe and a neutral red (NR) dye) simultaneously to the same set of cells to 
monitor different endpoints of toxicity (loss in metabolic activity, plasma membrane disruption, 
and/or lysosomal dysfunction, respectively) (Dayeh et al. 2005), and it has been adapted for use with 
mammalian cell lines (Lammel et al. 2013). Using the same methodology as has previously been 
outlined in Connolly et al. (2015) the cytotoxicity of the organic modifiers HDTA and TMSA, N116 
parent clay and organoclays N116_HDTA and N116_TMSA were assessed. As well as providing 
mechanistic information such a testing platform increases reliability by identifying any assay specific 
interactions leading to false positive results. Any interferences of clays/organoclays with specific 
assays reagents was fully assessed.    
2.7. Assessment of contribution of organic modifier to cytotoxicity  
In the N116_HDTA and N116_TMSA organoclays tested there is a proportion of modifier exchanged 
and a proportion that is free (not exchanged) that equates to the total amount of modifier used in 
the cation exchange process. To investigate the contribution of organic modifier to cytotoxicity and 
the extent to which the free and exchanged modifier contributes to the effect, dose response curves 
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obtained for the known amount of modifier used (total) and not exchanged (free) in the 
modification process were compared with those obtained for modified clays. 
2.8. Cytokine Analysis (J774.1 cells) 
Samples for cytokine analysis were taken from supernatants which were generated in cytotoxicity 
tests from immune cells which were exposed for 24 h to clays and organoclays and frozen at -80°C. 
Supernatants from cells exposed to sublethal concentrations (3.91 µg/cm2) of N116 and organoclays 
were analysed for levels of the pro-inflammatory cytokine, TNF-α. TNF-α levels were measured by 
ELISA according to the manufacturer’s instructions (DuoSet® ELISA, R&D Systems Inc. Minneapolis, 
MN, USA). Culture medium from cells exposed to lipopolysaccharide (LPS) (10 ng/mL) was included 
as a positive control. Samples were analysed in duplicate from three independent experiments. 
2.9. Clay-cellular interaction and uptake (J774.1 cells) 
Clay-cellular interaction was investigated through cytological staining techniques and cellular 
ultrastructural analysis. A romanowsky-type stain variant (Diff-Quik® Stain Kit (TCS Bioscience Ltd, 
Buckingham, UK)) was used for cellular nuclear and cytoplasmic staining of the J774.1 immune cells 
following exposure to clays to monitor the physical state of the cells and to differentiate or identify 
specific clay-cellular interactions. Cells were seeded on 10 mm glass coverslips (NuncTM Thermanox
TM 
plastic, Thermo Fisher Scientific, Cramlington, UK) at a density of 1.5 x106 cells/mL in 24 well plates. 
Following 30 min, 2 h, 4 h and 24 h exposure to sublethal concentrations of clay (7.82 µg/cm2) and a 
washing step (PBS, 150 µl), coverslips were dipped into a fixative solution followed by staining with a 
thiazine methylene blue dye and red Eosin G dye in phosphate buffer for nuclear and cytoplasmic 
staining, respectively. Stained coverslips were mounted on slides and viewed using a OLYMPUS IX70 
polarizing microscope (OLYMPUS, Southend-on-Sea, UK) equipped with a AxioCamERc 5s digital 
camera and filters for light polarization. 
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To investigate cellular uptake of clays, coverslips with J774.1 cells exposed to sublethal 
concentrations (3.91 µg/cm2) of N116 clays and N116_HDTA/TMSA for 24 h were prepared for TEM 
analysis. Exposed cells were fixed (3% glutaraldehyde for 2 h in sodium cacodylate buffer (0.1 M, 
pH7.3, room temperature)), washed (sodium cacodylate buffer x3), post fixed (1% osmium tetroxide 
for 45 mins in sodium cacodylate buffer), dehydrated in increasing concentrations of ethanol (50%, 
70%, 90% and 100% (15 minutes for each)), 10 minutes changes of propylene oxide. Processed 
samples were embedded in 812 resin (TAAB, Reading, UK) and ultrathin sections (600-1000 nm 
thick) were cut on a Leica Ultramicrotome (Leica Microsystems, Milton Keynes, UK . Sections were 
stained in uranyl acetate and lead citrate and then viewed in a JEOL JEM-1400 Plus TEM and 
micrographs taken using a GATAN OneView camera (GATAN, Pleasanton, CA, USA ) (Institute of 
Molecular Plant Sciences Electron Microscope facility, University of Edinburgh). 
2.10. Statistical analysis 
Data points presented in dose response curves are mean values (± standard error of the mean 
(SEM)) of at least three independent experiments. Significant differences among treatments and 
controls were determined by one-way analysis of variance (ANOVA, p < 0.05) followed by a 
Dunnett’s Post hoc test using GraphPad Prism version 6 software. Dose response curves were 
generated using the same software and applying four-parameter nonlinear regression to calculate 
the concentration of test compound  i.e clay, organoclay or organic modifier) that reduced cell 
viability by half (median inhibition concentration, IC50 values).  
3. Results  
3.1. Clay organic modification  
3.1.1. Fourier transform infrared (FT-IR) spectroscopy characterisation 
FTIR was used to confirm the presence of the HDTA and TMSA organic modifiers between and/or 
surrounding the clay layers. The attenuated total reflection (ATR) spectra of the unmodified clay 
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(N116), QAC organic modifiers HDTA and TMSA as well as the clays modified with HDTA 
(N116_HDTA) and TMSA (N116_TMSA) are presented in figure 2. The spectra of the clay shows a 
peak around 1200 cm−1, which corresponds to Si-O absorptions and OH bands that are typical of clay 
minerals (figure 2 (a)). Inner hydroxyl groups, lying between the tetrahedral and octahedral sheets, 
give the absorption peaks near 3620 cm−1 which are characteristic of bentonite clays (Ikhtiyarova et 
al. 2012). In the spectra of both the organic modifiers, stretching vibrations of the C−H bonds of the 
alkyl chain occur in the 2800 – 2950 cm-1 region as well as a characteristic C-H bending vibration of 
the (CH3)4N
+ cation at 1487 cm−1 (figure (b) and (d)). The presence of both these peaks in the spectra 
of the organoclays confirms the presence of the modifiers in the organoclays and a successful 
modification process (figure 2 (c) and (e)).  These peaks are absent in unmodified clays (figure 2(a)).  
 
Figure 2. ATR-FTIR spectra of nanoclays, organic modifiers and organoclays: (a) the sodium bentonite 
nanoclay, (b) organic modifier HDTA, (c) N116_HDTA organoclay, (d) organic modifier TMSA, (e) 
N116_TMSA organoclay.  
3.1.2. Thermogravimetric Analysis (TGA) ad X-ray diffraction (XRD)  
Following the modification process, it is expected that not all the modifier is incorporated into the 
structure of the clay (i.e. it does not intercalate). TGA was performed to calculate the percentage of 
intercalated or exchanged and non-intercalated free modifier in the organoclay preparations. 
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Thermogravimetric curves confirming the onset temperatures of degradation for organic modifiers 
were used to calculate the fraction of the weight loss coming from the non-intercalated (free) 
modifier and exchanged modifier in organoclay preparations. TGA curves are presented in additional 
file 2. showing the fraction of the weight loss that comes from the modifier non-intercalated and 
exchanged modifier that is decomposed at higher temperatures (upto 500°C). These values are 
presented as percentages of free and exchanged modifier in Table 1. Briefly, there is a similar level 
of incorporation of each modifier into the organoclay; 19.1% for HDTA, and 21.3% for TMSA (Table 
1). 
Any increases in the interlayer distance (d001) of the nanoclays were also calculated from X Ray 
diffractograms of the clays modified with HDTA and TMSA (as detailed in methods section) 
(diffractograms presented in Additional file 3, figure 1 and 2). The organic modification increased the 
interlayer distance of unmodified clays from 10.39 Å to 18.78 Å and 21.53 Å for HDTA and TMSA 
modified clays, respectively, suggesting that the modifiers were successfully integrated between the 
layers of the clay. 
Table 1 Content of organic modifiers in the organoclaysand interlayer distances. 
 
 
 
 
 
3.2. Physico-chemical characterisation of clay and organoclay suspensions 
Test suspensions of clays and organoclays were characterised prior to performing in vitro studies. 
According to the ENPRA protocol developed for dispersing nanomaterials, the clays were first 
suspended in 2% fetal calf serum. Bath sonication (16 minutes) was used to improve dispersion and 
thereafter test suspensions were prepared in relevant cell culture medium (Jacobsen et al. 2010). A 
 % Free % exchanged   d001 (Å)  
N116_1HDTA 8.2 19.1 18.78  
N116_1TMSA 8.2 21.3 21.53  
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detailed physico-chemical characterisation was performed on these test suspensions to gain 
information on the size and distribution of clay particles being tested under exposure conditions (24 
h at 37°C / 5% CO2 atmosphere).  
The hydrodynamic diameter and stability of clay dispersions in test suspensions was analysed using 
dynamic light scattering. Measurements were taken directly after preparation (T0 h) and 24 h post 
incubation at 37 °C. Z-average values are presented for comparative purposes showing the mean 
cumulative particle size for all clay suspensions. At T0 h unmodified N116 clays suspensions had a 
hydrodynamic diameter of 2681±133 nm. The N116_HDTA and N116_TMSA organoclay suspensions 
both had very similar, but larger mean particles sizes (5115±223 and 5516±216 nm, respectively) at 
this timepoint.  After 24 h there was no change in overall mean size distribution for any of the clay 
suspensions (Table 2). The polydispersity index (PdI) measured indicated a non-uniform distribution 
of clay particles with a wide variety of sizes present in all suspensions (PDI range; 0.267-0.662). The 
largest PDI value was measured for N116_TMSA organoclay suspensions following 24 h incubation.  
There was no obvious difference in distribution between the distinct media (MEM GlutaMAX™, RPMI 
1640, MEM high glucose) used to prepare suspensions for exposures to different cell types (data not 
shown).   
Table 2. Hydrodynamic diameter of unmodified (N116) and modified (N116_HDTA or N116_TMSA) 
clay particles in complete cell culture medium (100 µg/mL immediately after preparation (T0 h) and 
24 h post incubation at 37 °C. 
 PdI  Z-Av (d.nm ± sd)   T0h 
                                T24 h 
 
N116 0.267 
0.304 
2681 ± 133 
3276 ± 177 
 
N116_1HDTA 0.293 
0.402 
5515  ± 223 
5458  ± 274 
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Hydrodynamic size is represented as mean diameter (d.) ± standard deviation (sd) in nm and calculated from the average of three 
independent measurements. [%] represents the relative intensities of the different peaks.  PdI, polydispersity index; Z-Av, zeta-average. 
Light microscopy images of modified and unmodified clay suspensions prepared in complete culture 
medium also revealed a heterogeneous distribution of different sized clay particles (figure 3). The 
presence of large clay particles ≤45 µm as well as smaller particles ≤ 1 µm was evident in both N116 
clay (figure 3 (a)) and organoclay suspensions (figure 3 (b) and (c)). Interestingly in the culture 
medium environment the organoclay appear red in colour and there is an obvious change in colour 
of the medium, suggesting that components of the medium may adsorb onto the clay surface (figure 
3 (b) and (c)).  
 
Figure 3. Light microscope images of clay N116 (a), organoclay N116_HDTA (b), and organoclay 
N116_TMSA (c) suspended in complete culture medium at a concentration of 100 µg/mL, 
immediately after preparation. 
 
3.3. Hazard Assessment  
N116_1TMSA 0.475 
0.662 
5516  ± 216 
4611  ± 204 
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Interference checks were performed for each of the cytotoxicity assays (alamarBlue®, CFDA-AM and 
Neutral red uptake) prior to performing hazard assessments. A strong adsorption of the neutral red 
dye reagent to the organoclays and parent clay was observed (Additional file 4, figure 1 and 2). This 
led to a major interference of the clays with this assay and thus it was omitted from the cytotoxicity 
screen. No interference was detected with assay reagents or conversion products of the other two 
assays used (data not shown).  
 
3.4. Cytotoxicity of unmodified clay and organoclays 
Figure 4 shows the viability of HaCaT skin cells (a), C3A liver cells (b) and J774.1A immune cells (c) 
following exposure to the parent clay N116 and organoclays (N116_TMSA and N116_HDTA). Data 
obtained from the alamarBlue® assay are presented (figure 4) as it proved the most sensitive system 
for detecting cytotoxic effects of the clays, however similar trends were measured using the CFDA-
AM assay (data not shown). Both organoclays caused a concentration-dependent reduction in 
viability in the three different cell types, in both assays. The N116_TMSA organoclay was most 
cytotoxic to all cell types, causing a significant (p<0.05) reduction in cell viability at concentrations ≥ 
0.98 µg/cm2, whilst N116_HDTA significantly reduced cell viability at concentrations ≥1.95 µg/cm2. In 
contrast the parent (unmodified) N116 clay only elicited a concentration dependent decrease in cell 
viability in J774.1 macrophage-like cells, with a significant reduction of cell viability observed at 
concentrations ≥7.81 µg/cm2. In the skin and liver cells, viability remained above 80% following 
exposure to the highest concentration of the parent clay tested (31.25 µg/cm2) (figure 4 (a) and (b)).  
The IC50 values calculated from the dose response curves of the alamarBlue® and CFDA-AM assay 
systems for unmodified and modified clays in each cell type are presented in Table 3, along with IC50 
values calculated from exposures of cells to the modifiers alone (HDTA and TMSA). Due to the low 
levels of reduced viability measured in both assay systems IC50 values could not be calculated 
following exposure of HaCaT and C3A cells to the unmodified N116 parent clay. The IC50 values 
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calculated following exposure of J774.1 cells to unmodified N116 were 24.3 and 91.3 µg/cm2 
according to the alamarBlue® and CFDA-AM assays. The IC50 values calculated for N116_HDTA and 
N116_TMSA organoclays ranged from 8.3 – 93 µg/cm2 and 3.2– 19.8 µg/cm2 respectively, according 
to the cell type and assay system applied. Using the IC50 values for all cell types the clays can be 
ranked N116_TMSA>N116_HDTA>N116 in hazard potential. Lower IC50 values were calculated using 
the alamarBlue® assay in all cell types indicating its increased sensitivity, compared to the CFDA-AM 
assay. J774.1 cells were the most sensitive cell type with the lowest IC50 values calculated for all test 
substances will cell sensitivity ranked: J774.1>HaCaT>C3A. 
The IC50 values calculated following exposures with organic modifiers only were lower, ranging from 
0.46-18.75 µg/ cm2 and 0.47-16.9 µg/ cm2 for HDTA and TMSA respectively, again depending on the 
cell type and assay system applied. Similar IC50 values calculated for HDTA and TMSA indicate that 
the organic modifiers have a similar hazard potential however a distinct cell-type sensitivity order 
can be made as follows HaCaT> J774.1>C3A.  
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Figure 4. Levels of viability in HaCaT skin cells (a), C3A liver cells (b) and J774.1 macrophage-like cells 
(c) following 24 h exposure to a range of concentration (0.12- 31.25 µg/cm2) of clay N116 and 
organoclays (N116_HDTA, N116_TMSA) (expressed as average % untreated control cells ± SEM and 
measured according to the alamarBlue® assay). Significance differences compared to control 
untreated cells are represented by  * p ≤ 0.05 (n=3). 
Table 3. Comparison of IC50 values (in ug/cm2) calculated for modified and unmodified clays and the 
organic modifiers in HaCaT skin cells, C3A liver cells and J774.1A macrophage-like cells.    
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(-) Indicates that the IC50 could not be calculated, AB, alamarBlue® assay, CFDA-AM, 5-carboxyfluorescein diacetate, acetoxymethyl ester (CFDA-AM) probe 
3.5. Contribution of organic modifier to organoclays cytotoxicity 
Based on knowledge about how much of the modifier was incorporated into the organoclay and 
remained free (from TGA and XRD analysis), and the known responses following exposure to 
modifier alone, the contribution of intercalated and/or free concentrations of modifier to organoclay 
cytotoxicity could be assessed. In figure 5, to identify the role of organic modifier in HaCaT cell 
cytotoxicity, concentration response curves for cell viability were compared to expected viability 
levels when the concentration of the modifer was expressed as total and free concentration. 
The concentration response curve for N116_HDTA organoclay corresponds to that of the free 
modifier for the HaCaT cells (figure 5). This is evident in both assay systems employed (figure 5 (a) 
and (b)) and suggests that the free modifier is responsible for the toxicity of N116_HDTA toxicity. In 
contrast the N116_TMSA concentration response curve lies between that generated for the total 
and free modifier dose response according to the alamarBlue® (figure 5(c)) and almost on top of the 
total modifier dose response curve according to the CFDA-AM assay (figure 5(d)). Therefore, for 
N116_TMSA both the free and exchanged modifier (total) are likely to contribute to the toxicity 
observed to HaCaT skin cells.  
Accordingly, despite similar levels of incorporation into the clay (according to TGA analysis) (27.3% 
and 29.5% (w/w) for N116_ HDTA and N116_TMSA, respectively), as well as free modifier content 
(8.2 % (w/w), there are different contributions from organic modifiers to the cytotoxicity of the 
organoclays. 
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In figure 6 the contribution of organic modifier (total or free concentrations) to organoclay 
cytotoxicity to J774.1 cells was assessed. In contrast to the distinct contribution from free 
(N116_HDTA) and total modifier (N116_TMSA) seen in HaCaT cells (figure 5) dose response curves 
generated from organoclay exposure to J774.1 cells either lie directly on top of curves for total 
modifier contribution or show a steeper hill slope (figure 6 (b) and (a)(c)(d) respectively). This would 
indicate a unique contribution from both the clay and organic modifier in both N116_HDTA and 
N116_TMSA cytotoxicity in J774.1 cells and a possible additive or synergistic effect.  
 
 
Figure 5. Comparing the contribution of total concentration of organic modifier and free (non-
exchanged) modifier to N116_HDTA (a)(b) and N116_TMSA (c)(d) cytotoxicity to HaCaT skin cells.  
Bold solid lines denote the observed response from organoclay exposure (n=3). Dashed lines 
represent the calculated effects (extrapolated from dose responses) from known concentration of 
total modifier (white circles) and only the free portion (non-exchanged) (white squares).   
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Figure 6. Comparing the contribution of total concentration of organic modifier and free (non-
exchanged) modifier to N116_HDTA (a)(b) and N116_TMSA (c)(d) cytotoxicity to J774.1 macrophage-
like cells.  Bold solid lines denote the observed response from organoclay exposure (n=3). Dashed 
lines represent the calculated effects (extrapolated from dose responses) from known concentration 
of total modifier (white circles) and only the free portion (non-exchanged) (white squares).   
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3.6. TNF-α cytokine release from J774 cells 
J774.1 cells were most sensitive to the toxicity of the parent and modified clays when cytotoxicity 
was used as an indicator of toxicity. To further investigate toxicity to these cells, the production of 
the pro-inflammatory cytokine TNF-α was assessed following exposure to sublethal concentrations 
of the clays (figure 7). Interestingly a significant (p<0.05) increase in TNF-α levels (454 ±13 pg/mL) 
was measured in the supernatants of the parent N116 clay exposed cells, while no significant 
increase in TNF-α levels were detected in both N116_HDTA and N116_TMSA cell supernatants (241 
±20 pg/mL and 276 ± 14 pg/mL, respectively) compared to control untreated cells (164 ±2 pg/mL).  
 
 
Figure 7. Levels of tumor necrosis factor (TNF)- α secretion from J774.1 cells following 24 h exposure 
to N116 clay and organoclays N116_HDTA and N116_TMSA (3.91 µg/cm2).  Levels of production 
from cells exposed to cell culture medium (control) and exposed to lipopolysaccharide (LPS) (10 
ng/ml) (+ control) are also shown. Data is expressed as mean ± SEM (n=3). Significance differences 
compared to control untreated cells are represented by * p ≤ 0.05.  
3.7. Clay-cellular interactions and uptake 
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The interaction of the clays with J774.1 cells was studied by light microscopy. Images of J774.1 cells 
stained using the commercial Diff-Quik® staining kit are presented in figure 8. For N116 exposed 
cells, the clays can be clearly identified and distinguished from cells as smaller dark spherical 
assemblages. A high level of clay-cellular interaction was seen even after 2 h exposure (figure 8 (b)). 
After 4 h clays are visible at the cell membrane and junctions between individual cells. Clays also 
appear to be internalised (figure 8 (c). However, in order to confirm the uptake of clays by cells TEM 
was used as it is challenging to distinguish particles associated with the cell surface with those that 
are internalised using light microscopy.  
 
 
Figure 8. Cytological examination of J774.1 macrophages unexposed (control cells) (a) and when 
exposed to N116 clays (7.82 µg/cm2) for 2 h (b) 4 h (c). Black arrows indicate stained clays and their 
interaction with cell surface. 
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Further investigations were performed using TEM analysis to positively identify uptake of clays by 
J774.1 cells. Figure 9 (a) and (b) compare the cellular ultrastructure of unexposed cells and cells 
exposed to N116_HDTA organoclays, respectively. The presence of clay particles in multiple 
intracellular vesicles within the exposed cell cytoplasm is evident. A number of clay particles are 
present in each vesicle, with vesicles measuring from 500-1000 nm in diameter. Depending on the 
clay particles orientation they appear as sheets 100-200 nm in diameter or as thin fibres~1nm thick. 
A micrograph showing the clay particles sheet-like structure and the presence of individual high 
aspect ratio sheets is presented in figure 9c. Individual layers stacked to form clay particles can be 
viewed as well as single individual layers with high aspect ratio. Further micrographs of exposed 
J774.1 cells (figure 9 (d) and (e)) show the presence of both clay particles and individual clay sheets 
contained within membrane vesicles.  
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Figure 9. TEM micrographs of unexposed J774.1 cells (a), J774.1 cells exposed to organoclays 
(N116_HDTA) (b), showing structure of clays under acellular conditions (N116_HDTA) (c) and when 
present in intracellular vesicles of J774.1 cells (d and e). Solid white boxes were used to highlight the 
presence of clay particles in intracellular vesicles Black arrows have been used to indicate individual 
clay sheets while larger layered clay particles are inside dashed white box. Inserts also show clay 
particles in vesicles at higher magnification.   
 
4. Discussion 
It is important to consider both safety and functionality in the rational design of clays for application 
in consumer products. Organic modification of clays renders them compatible with polymer 
matrices, so they can be used as nanofillers in polymer-clay nanocomposite materials for the 
packaging industry. However, the organic modification may change the safety profile of the resulting 
organoclay. In this study two organoclays were produced (N116_HDTA and N116_TMSA) from a 
commercially available parent sodium bentonite clay by performing a cation exchange reaction with 
the QACs HDTA and TMSA. These organoclays are being investigated for their use in nanocomposite 
packaging materials for the cosmetic industry. The hazard of these organoclays was assessed in vitro 
using a panel of relevant cell types (skin, liver, and macrophage-like cells) and a battery of 
cytotoxicity assay systems (alamarBlue® and CFDA-AM assays) were used to compare the potency of 
the organoclays and identify differences in cell sensitivity to the organoclays. The use of in vitro 
models to screen particle toxicity has recently been proposed as a key component of intelligent 
testing strategies to allow risk evaluation of nanomaterials (Farcal et al. 2015; Stone et al. 2014), and 
to improve alignment of nanotoxicology testing with the 3Rs principles (Burden et al., 2017; 
Johnston et al., 2018).  
4.1. Effect of organic modification on the physico-chemical properties of the clays 
FT-IR analysis confirmed the exchange of Na+ cations on the surface of clay layers with 
alkylammonium ions of the HDTA and TMSA organic modifiers. The interlayer distance measured 
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increased from 10.39 Å in the parent clay to 18.78 Å and 21.53 Å in the N116_HDTA and TMSA 
organoclays, respectively. This increase in interlayer distance will facilitate polymer intercalation 
between individual clay layers during polymer nanocomposite production (Jang et al. 2005). The 
concentration of modifier present within, or surrounding, the clay layers was identified to be 27.3% 
HDTA (w/w) and 29.5% TMSA (w/w). However, the total content of organic modifier in the 
organoclays consisted of both an exchanged (i.e. intercalated) and free (non-intercalated) portion 
(approx. 8%) that likely contributed to the adverse effects observed.  
In the cytotoxicity studies performed the parent clay and organoclays were first suspended in 
aqueous suspensions (2% FCS) and subsequently test suspensions were prepared in cell culture 
media for application to cells. These clays have swelling properties and therefore an expansion of 
interlayer spacing would be expected in these aqueous suspensions. The degree to which expansion 
would take place would dictate whether the clay particles remained as tactoids (stacks of parallel 
clay sheets with equal interlayer spacing) or became delaminated (broken down into individual clay 
sheets). Images taken of the clay suspensions showed the presence of large clay particle tactoids 
(1.6-4.4 µm) as well as smaller populations of clay particle tactoids (300-900 nm) in both parent and 
organoclay suspensions. When viewed at higher magnification using transmission electron 
microscopy, there was evidence of both tactoids and individual high aspect ratio delaminated clay 
sheets. Hydrodynamic size measurements taken directly following preparation and after incubation 
at 37 °C did not reveal any significant changes in clay particle sizes in biological medium. The clay 
particles under investigation were between 2-6 µm in diameter. Larger z-average values were 
measured in organoclay suspensions suggesting a greater tendency to form larger clay particles and 
flocculate in aqueous suspension. This is most likely due to the hydrophobic properties of these clays 
following modification. 
The use of a dispersant such as serum is known to create a steric stabilisation effect (Moore et al. 
2015) and thus was used to help create homogenous suspensions of the clays for testing. Also, in 
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this particular case, the clays have strong adsorption properties and complexation abilities and thus 
the addition of a serum coating step could reduce potential clay-media interactions that may have a 
direct influence on physico-chemical properties and the hazard assessment (Katic et al. 2006). 
Hydrodynamic size measurements point to the overall stability of clay/organoclay suspensions in 
biological media. However, imaging of the clay suspensions using light microscopy revealed that 
organoclay particles appeared opaque and red. The findings from this study suggest that the 
organoclays have a higher capacity to adsorb media components than the parent, unmodified clay. 
The strong affinity of clays for cationic and anionic dyes has been reported previously and attributed 
to the negatively charged surface lattices found in clays (Ramakrishna and Viraraghavan 1997). In 
this study the organic modification has markedly increased the clays uptake of the organic dye 
phenol red, a common constituent in culture medium used as a pH indicator. A strong interaction of 
the cationic surfactant HDTA with anionic phenol red has also been reported previously (Nong et al. 
2014). Research performed into this phenomenon has shown that adsorption occurs due to 
electrostatic attraction and hydrogen bonding between the amine on the organoclay and the dye 
and that this can actually be tuned for potential applications (Chen et al. 2017).  
However, in the context of this study the high adsorption properties of the clays have also led to 
interference with one of the assay systems employed. More specifically, the clays strongly adsorbed 
to the neutral red cationic dye used in the cytotoxicity screening to assess possible lysosomal 
dysfunction in the Neutral red assay. The importance of assessing for interference when testing 
nanomaterials using in vitro systems is well known (Stone et al. 2009; Ong et al. 2014) but has not 
been reported for clays previously. As many of the in vitro assays commonly applied to assess cell 
function make use of dyes, careful consideration needs to be taken and a thorough interference 
check performed when testing the toxicity of clays. Indeed, the neutral red uptake assay was 
excluded from this study due to interference issues.  
4.2. Effect of organic modification on clays toxicological/safety profile 
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Both of the organoclays tested produced higher and distinct cytotoxic effects relative to the parent 
nanoclay in all cell types. This highlights an increased hazard from organoclays that should be 
acknowledged within a risk assessment framework. This is consistent with reports in a number of 
other studies assessing clay toxicity using different organic modifiers and cell types (e.g. Janer et al. 
2014). For example, the commercially available organoclay, Cloisite®30B which is modified with 
methyl, tallow, bis-2-hydroxyethyl, quaternary ammonium (CAS no. 91721-84-5) produced distinct 
cytotoxic effects in both the human intestinal epithelial cell Line, Caco-2 (24 h EC50 value was 79 ± 4 
μg/ml (24.68 ±1 ug/cm2) (Maisanaba et al. 2014) and the human bronchial epithelial cell line, BEAS-
2B (Wagner et al. 2017).  
In this study a significant reduction in cellular metabolic activity (alamarBlue® Assay) was measured 
following administered doses of ≥1.95 µg/cm2 and 0.98 µg/cm2 for N116_HDTA and N116_TMSA, 
respectively. These LOEC values are only slightly higher than theoretical exposure levels calculated 
following the use of a cosmetic packaging incorporating 4% (w/w) organoclay nanofiller (0.8 µg/cm2) 
(Additional file 1, figure 1). Therefore, it would be important in the packaging design process to 
minimise the amount of organoclays that are incorporated into the packaging and ensure low 
migration from the packaging into the cosmetic in order to mitigate potential risks to the consumer 
from exposure. A study investigating actual migration levels from nanocomposites incorporating 
N116_HDTA and N116_TMSA is currently being performed and this exposure information along with 
the toxicological information generated in this study will contribute to a complete risk assessment 
for the packaging being developed (Connolly et al, manuscript in preparation).    
The identification of specific modes/mechanisms of action that lead to adverse effects is key to a 
better understanding of hazard potential. A recent comprehensive investigation, that included a 
range of modified montmorillonite clays with different modifiers, showed that the chemical 
composition and structure of the modifiers played a major role in the adverse effects of organoclays 
(Wagner et al. 2017). In this study we have investigated the specific contribution of organic modifier 
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to cytotoxicity and confirmed the role of free HDTA and TMSA modifiers in the toxicity observed. 
These QACs belong to a class of cationic surfactants commonly used in household cleaning products, 
disinfectants and personal care products. They have positively charged head groups and therefore 
have a strong tendency to adsorb to negatively charged surfaces (e.g. cell membranes). Also, as a 
group, QACs are known skin and respiratory irritants with different degrees of irritation depending 
on the alkyl chain length and structure of the molecule (Rhein et al. 1986, Lin and Hemming 1996). 
Therefore, the concentration of organic modifiers such as HDTA or TMSA present on or intercalated 
with the clay is likely to dictate toxic potency.  
Interestingly, in this study TMSA modified clays were more cytotoxic compared to HDTA modified 
clays despite both organic modifiers producing similar cytotoxic effects when tested alone (IC50 0.46 
vs 0.47 µg/cm2). To better understand this, the toxic contribution of both the known free, as well as 
exchanged, concentrations of HDTA and TMSA in organoclay exposure suspensions was determined. 
There was a positive correlation between total organic modifier contributions and N116_TMSA 
exposure response curves not seen in the case of N116_HDTA (positive correlation with free 
modifier concentration). Such a finding may point to the TMSA modifier becoming displaced from 
the clay surface in the cell culture medium environment (during preparation or during the exposure 
period) and mediating the toxicity observed. Such a phenomenon has been witnessed by Sharma 
and colleagues when dispersing a natural montmorillonite modified with the quaternary ammonium 
salt methyl, tallow, bis-2-hydroxyethyl (Cloisite® 30B) in DMEM cell culture medium (Sharma et al. 
2014). Interestingly the authors observed no release of organic modifier in water. Cations in the 
culture medium (e.g. Ca2+, Na+) may be participating in exchange reactions with the clays and 
causing the displacement of the ammonium cations of the organic modifiers. This exchange process 
has been shown to be influenced by free energies of hydration, differences in head groups of organic 
modifiers as well as the strength of van der Waals forces (Teppen et al. 2007). The release of 
surfactants from the Nanomer1.44P and Cloisite 93A organoclays in food simulants (ethanol (100%), 
50% ethanol (ethanol/water = 1:1, v/v) and water (100%)) has been studied and found to be 
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influenced by temperature, the affinity between the surfactant and the solvent, with the highest 
release measured in 100% ethanol (Xia et al. 2015). As well as explaining the increased cytotoxicity 
of TMSA modified organoclays seen in our study, it is possible that the increased cytotoxicity 
reported by other authors for organically modified clays using in vitro cell culture test systems may 
be explained by similar displacement (e.g. Wagner et al. 2017; Cloisite 30B and BEAS-2B cells) 
(Sharma et al. 2010; Cloisite® 30B and Caco-2 cells)). The results obtained can be used to inform the 
safe development of future generations of modified clays (i.e. by informing the selection of the 
modifier and ensuring stability of modification) and also has implications for the safe use of polymer 
nanocomposites made using organically modified clays. 
While experimental conditions, in this case, has influenced results, this might also mimic what may 
occur in a biological environment in-vivo (e.g. following ingestion in the gastrointestinal tract of rats 
because of chemical reaction with proteins or amino acids or displacement caused by salts).   
Macrophages were observed to be the most sensitive cell type to both the parent clay and 
organoclays tested. This may arise as a consequence of the phagocytosis of organoclays into 
lysosomes, which is likely to cause displacement of the organic modifier and the elicitation of 
cytotoxicity through organic modifier mediated mechanism of toxicity. Macrophages are 
professional phagocytes, and the ability of macrophages to take up such large particles (≥1um) via 
phagocytosis/micropinocytosis has been demonstrated previously (Kuhn et al. 2014). Furthermore, 
non-phagocytic cell types (e.g. hepatocytes, epithelial cells) can also internalise particles (Panzarini 
et al. 2018). A lysosomal-enhanced trojan horse type mechanism of cytotoxicity has been proposed 
for a variety of metal containing nanomaterials that are susceptible to dissolution processes (e.g. 
Sabella et al. 2014). The uptake of organoclays in lysosomes that have acidic environments is likely 
to affect clay-modifier interactions. For example, using liposomes with lipid bilayers as a model to 
study the mechanism of toxicity of surfactants at the cellular level Hamada and colleagues (Hamada 
et al. 2012) showed a distinct mechanism of membrane solubilization induced by various 
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surfactants. Further studies would need to be performed to investigate the increased sensitivity of 
macrophages (and how this relates to particle uptake) and potential modifier displacements in such 
intracellular environments and subsequent surfactant effects on lysosomal membranes.  
4.3. Cell-type specific and organoclay-specific effects  
In this study, the toxicity of clay and organoclay test suspensions were tested across different cell 
models (skin, liver and macrophage-like cells). J774.1 macrophage-like cells were the most sensitive 
cell type to the parent sodium bentonite clay tested in this study. Cytotoxic effects were measured 
at concentrations ≥7.81 µg/cm2 and a complete loss in viability was measured following exposure to 
the highest concentration tested (31.25 µg/cm2). In contrast, the HaCaT skin epithelial and C3A 
hepatocyte cells only exhibited slight reductions (5-10%) in viability even at the highest 
concentration tested. Other authors have also observed the increased sensitivity of macrophages to 
cytotoxic effects of aluminium silicate clay minerals (Bowman et al. 2011; RAW murine macrophage 
cells), amorphous silica (Costantini et al. 2011; mouse alveolar macrophage (MH-S) cells) as well as 
other nanomaterials (Lanone et al. 2009; Brown et al., 2018). These cells are highly phagocytic in 
nature and thus the increased susceptibility of this cell line to the clay may be related to an 
increased intracellular uptake. The physiological role of macrophages in the clearance of foreign 
material may result in a more rapid phagocytic uptake of clays and a higher exposure concentration 
to cells (Malugin et al. 2011). TEM analysis has confirmed the uptake of numerous laminated clays in 
membrane bound vesicles. While hepatocytes and keratinocytes have been shown to internalise 
particles (Johnston et al. 2010; Li et al. 2016), a detailed comparative and quantitative study would 
need to be performed to confirm clay uptake across the cell types. Histocytological staining however 
has shown clay-cellular interactions with clays accumulation at the macrophage cell surface 
observed. This together with early reports of cytotoxic effects of clays involving rapid association of 
clays with the outer membrane of cells and complete cell lysis (Murphy et al. 1993) may render 
J774.1 cells more sensitive to the clays than the other cell types investigated. The release of TNF-α 
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following clay exposure only further supports a distinct clay-induced mechanism of toxic action in 
the J774.1 macrophage-like cells that warrants further investigation. Clays have been shown to 
stimulate antigen presenting cell maturation, so much so that they have been highlighted as 
potential nano-adjuvants for enhancing immune responses (Chen et al. 2017). This distinct effect 
could be related to the reported silica sensitivity in macrophages as the silica content of bentonite 
clays can range from 1-20% (Gozal et al. 2002). More specifically, TNF-α has been identified as a 
major determinant in the development and progression of silicosis (Piguet et al. 1990). Bentonite 
clays have been shown to be more cytotoxic to human B lymphoblast cells than even DQ-12 
crystalline silica, a substance commonly used in studies as a positive control for its fibrogenic 
properties (Zhang et al. 2010).  
The presence of the organic modifier increased the cytotoxic effects of the parent clay suggesting 
that both modifier and particle effects contributed to the observed toxicity. By comparing 
concentration-response curves for organoclay responses and total concentrations of modifier 
present, a specific contribution of clay particles to cytotoxic effects is evident. Increased TNF-α levels 
were only measured following exposure to the unmodified clay. Modified clays show increased 
absorptive properties which may lead to interferences with cytokine levels through cytokine-clay 
interactions (Brown et al. 2010). Also, potential endotoxin contamination on unmodified clays that 
lack biocidal properties may explain such contrasting results. However, it may also indicate a distinct 
inflammatory response. Distinct mechanisms of cytotoxicity for unmodified clays involving reactive 
oxygen species (ROS) production (Lordan et al. 2011) and modified clays producing specific 
genotoxic effects (Sharma et al. 2010) have been reported previously. Also, genetic damage and lipid 
peroxidation was evidenced in workers occupationally exposed to bentonite clays modified with 
organic amine (including alkyl quaternary ammonium salt and methyl chloride) in a controlled 
experiment by Huang et al. (2013). Taken together the adverse effects reported in this in vitro study, 
and likely high exposure levels of workers to the clays and organoclays through inhalation suggests 
that they could represent a health risk. Appropriate risk management strategies (e.g. ventilation and 
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enclosures) incorporated during nanocomposite compounding have been shown to reduce airborne 
clay particle concentrations and thus minimize the health risks to workers (Tsai et al. 2012). 
5. Conclusions 
Organic modification of a sodium bentonite clay with the QACs HDTA or TMSA increased the hazard 
of this material, in a consumer and occupational setting. Cytotoxic effects were observed in all of the 
cell types tested (skin, liver and macrophage-like cells) for organoclays, and were dictated by the 
concentration of free or displaced modifier. Thus, the results suggest that the concentration of 
modifier used, as well as the stability of the exchange/intercalation must be considered in the 
context of a safety assessment for modified clays. The enhanced toxicity of modified clays may 
present a safety concern as the use of organoclays in polymer nanocomposites for packaging 
applications in different sectors (e.g. food and beverage) becomes more widespread. The parent 
N116 clay also produced cytotoxic effects at much lower concentrations compared to the 
organoclays in J774.1 macrophage-like cells, and stimulated TNF-α release.  This may point to 
particular occupational hazards associated with the inhalation of such materials with a high 
dustiness factor and subsequent contact with alveolar macrophages in the lungs. However, it is 
important to distinguish between a non-adverse, physiological immune response stimulated by clays 
and a pathological inflammatory response. In vivo studies with clays are scarce (Warheit et al. 2010) 
and will need to be performed to assess how the results obtained from an in vitro study translate to 
possible effects in vivo, particularly following inhalation. This will enable an occupational risk 
assessment for the packaging to be performed. The in vitro toxicological information obtained in this 
study can be used to inform what measures need to be taken along the polymer-nanocomposite 
production chain to mitigate risk both to the consumer and workers in a safe by design concept and 
responsible development approach to sustainable nanotechnologies.  
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Highlights  
• Organic modification increases hazard of clays in vitro 
• Macrophages were most sensitive to the toxicity of clays 
• Modification stability of clays should be considered when testing in vitro 
 
 
 
 
 
 
 
